- Home
- COOT vs CODX Comparison
COOT vs CODX Comparison
Compare COOT & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COOT
- CODX
- Stock Information
- Founded
- COOT 2020
- CODX 2013
- Country
- COOT Australia
- CODX United States
- Employees
- COOT N/A
- CODX N/A
- Industry
- COOT
- CODX Medical/Dental Instruments
- Sector
- COOT
- CODX Health Care
- Exchange
- COOT NYSE
- CODX Nasdaq
- Market Cap
- COOT 23.0M
- CODX 22.0M
- IPO Year
- COOT N/A
- CODX 2017
- Fundamental
- Price
- COOT $1.25
- CODX $0.71
- Analyst Decision
- COOT
- CODX Hold
- Analyst Count
- COOT 0
- CODX 1
- Target Price
- COOT N/A
- CODX $1.50
- AVG Volume (30 Days)
- COOT 14.6K
- CODX 139.9K
- Earning Date
- COOT 01-01-0001
- CODX 03-13-2025
- Dividend Yield
- COOT N/A
- CODX N/A
- EPS Growth
- COOT N/A
- CODX N/A
- EPS
- COOT N/A
- CODX N/A
- Revenue
- COOT $23,793,673.00
- CODX $7,321,012.00
- Revenue This Year
- COOT N/A
- CODX N/A
- Revenue Next Year
- COOT N/A
- CODX N/A
- P/E Ratio
- COOT N/A
- CODX N/A
- Revenue Growth
- COOT 16.10
- CODX 57.16
- 52 Week Low
- COOT $0.61
- CODX $0.65
- 52 Week High
- COOT $10.00
- CODX $2.23
- Technical
- Relative Strength Index (RSI)
- COOT 46.64
- CODX 43.93
- Support Level
- COOT $1.22
- CODX $0.69
- Resistance Level
- COOT $1.57
- CODX $0.73
- Average True Range (ATR)
- COOT 0.14
- CODX 0.04
- MACD
- COOT -0.01
- CODX 0.00
- Stochastic Oscillator
- COOT 27.48
- CODX 42.31
About COOT AUSTRALIAN OILSEEDS HOLDINGS LTD
Australian Oilseeds Holdings Ltd through its subsidiaries, is focused on the manufacture and sale of chemical-free, non-GMO, sustainable edible oils and products derived from oilseeds. The company believes that transitioning from a fossil fuel economy to a renewable and chemical-free economy is the solution to many health problems the world is facing presently.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.